1 Recombinant Human Interleukin 2 Injection Market Overview 1.1 Product Overview and Scope of Recombinant Human Interleukin 2 Injection 1.2 Recombinant Human Interleukin 2 Injection Segment by Type 1.2.1 Global Recombinant Human Interleukin 2 Injection Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 50000 U 1.2.3 100000 U 1.2.4 200000 U 1.2.5 500000 U 1.2.6 1 Million U 1.2.7 Other 1.3 Recombinant Human Interleukin 2 Injection Segment by Application 1.3.1 Global Recombinant Human Interleukin 2 Injection Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Recombinant Human Interleukin 2 Injection Market Size Estimates and Forecasts 1.4.1 Global Recombinant Human Interleukin 2 Injection Revenue 2017-2028 1.4.2 Global Recombinant Human Interleukin 2 Injection Sales 2017-2028 1.4.3 Recombinant Human Interleukin 2 Injection Market Size by Region: 2017 Versus 2021 Versus 2028 2 Recombinant Human Interleukin 2 Injection Market Competition by Manufacturers 2.1 Global Recombinant Human Interleukin 2 Injection Sales Market Share by Manufacturers (2017-2022) 2.2 Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Recombinant Human Interleukin 2 Injection Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Recombinant Human Interleukin 2 Injection Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Human Interleukin 2 Injection Market Competitive Situation and Trends 2.5.1 Recombinant Human Interleukin 2 Injection Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Interleukin 2 Injection Players Market Share by Revenue 2.5.3 Global Recombinant Human Interleukin 2 Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Human Interleukin 2 Injection Retrospective Market Scenario by Region 3.1 Global Recombinant Human Interleukin 2 Injection Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Recombinant Human Interleukin 2 Injection Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Recombinant Human Interleukin 2 Injection Market Facts & Figures by Country 3.3.1 North America Recombinant Human Interleukin 2 Injection Sales by Country 3.3.2 North America Recombinant Human Interleukin 2 Injection Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Recombinant Human Interleukin 2 Injection Market Facts & Figures by Country 3.4.1 Europe Recombinant Human Interleukin 2 Injection Sales by Country 3.4.2 Europe Recombinant Human Interleukin 2 Injection Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Human Interleukin 2 Injection Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Human Interleukin 2 Injection Sales by Region 3.5.2 Asia Pacific Recombinant Human Interleukin 2 Injection Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Recombinant Human Interleukin 2 Injection Market Facts & Figures by Country 3.6.1 Latin America Recombinant Human Interleukin 2 Injection Sales by Country 3.6.2 Latin America Recombinant Human Interleukin 2 Injection Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Human Interleukin 2 Injection Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country 3.7.2 Middle East and Africa Recombinant Human Interleukin 2 Injection Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Recombinant Human Interleukin 2 Injection Historic Market Analysis by Type 4.1 Global Recombinant Human Interleukin 2 Injection Sales Market Share by Type (2017-2022) 4.2 Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Type (2017-2022) 4.3 Global Recombinant Human Interleukin 2 Injection Price by Type (2017-2022) 5 Global Recombinant Human Interleukin 2 Injection Historic Market Analysis by Application 5.1 Global Recombinant Human Interleukin 2 Injection Sales Market Share by Application (2017-2022) 5.2 Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Application (2017-2022) 5.3 Global Recombinant Human Interleukin 2 Injection Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Jiangsu Jinsili Pharmaceutical 6.1.1 Jiangsu Jinsili Pharmaceutical Corporation Information 6.1.2 Jiangsu Jinsili Pharmaceutical Description and Business Overview 6.1.3 Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio 6.1.5 Jiangsu Jinsili Pharmaceutical Recent Developments/Updates 6.2 3SBio 6.2.1 3SBio Corporation Information 6.2.2 3SBio Description and Business Overview 6.2.3 3SBio Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.2.4 3SBio Recombinant Human Interleukin 2 Injection Product Portfolio 6.2.5 3SBio Recent Developments/Updates 6.3 Beijing SL Pharm 6.3.1 Beijing SL Pharm Corporation Information 6.3.2 Beijing SL Pharm Description and Business Overview 6.3.3 Beijing SL Pharm Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Beijing SL Pharm Recombinant Human Interleukin 2 Injection Product Portfolio 6.3.5 Beijing SL Pharm Recent Developments/Updates 6.4 Shanghai Huaxin Biology Gaojishu 6.4.1 Shanghai Huaxin Biology Gaojishu Corporation Information 6.4.2 Shanghai Huaxin Biology Gaojishu Description and Business Overview 6.4.3 Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Product Portfolio 6.4.5 Shanghai Huaxin Biology Gaojishu Recent Developments/Updates 6.5 Beijing Four Rings Biopharmaceutical 6.5.1 Beijing Four Rings Biopharmaceutical Corporation Information 6.5.2 Beijing Four Rings Biopharmaceutical Description and Business Overview 6.5.3 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio 6.5.5 Beijing Four Rings Biopharmaceutical Recent Developments/Updates 6.6 Beijing Yuance Pharmaceutical 6.6.1 Beijing Yuance Pharmaceutical Corporation Information 6.6.2 Beijing Yuance Pharmaceutical Description and Business Overview 6.6.3 Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio 6.6.5 Beijing Yuance Pharmaceutical Recent Developments/Updates 6.7 Shandong Quangang Pharmaceutical 6.6.1 Shandong Quangang Pharmaceutical Corporation Information 6.6.2 Shandong Quangang Pharmaceutical Description and Business Overview 6.6.3 Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio 6.7.5 Shandong Quangang Pharmaceutical Recent Developments/Updates 7 Recombinant Human Interleukin 2 Injection Manufacturing Cost Analysis 7.1 Recombinant Human Interleukin 2 Injection Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Human Interleukin 2 Injection 7.4 Recombinant Human Interleukin 2 Injection Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Human Interleukin 2 Injection Distributors List 8.3 Recombinant Human Interleukin 2 Injection Customers 9 Recombinant Human Interleukin 2 Injection Market Dynamics 9.1 Recombinant Human Interleukin 2 Injection Industry Trends 9.2 Recombinant Human Interleukin 2 Injection Market Drivers 9.3 Recombinant Human Interleukin 2 Injection Market Challenges 9.4 Recombinant Human Interleukin 2 Injection Market Restraints 10 Global Market Forecast 10.1 Recombinant Human Interleukin 2 Injection Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Human Interleukin 2 Injection by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Recombinant Human Interleukin 2 Injection by Type (2023-2028) 10.2 Recombinant Human Interleukin 2 Injection Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Human Interleukin 2 Injection by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Recombinant Human Interleukin 2 Injection by Application (2023-2028) 10.3 Recombinant Human Interleukin 2 Injection Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Human Interleukin 2 Injection by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Recombinant Human Interleukin 2 Injection by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Recombinant Human Interleukin 2 Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Recombinant Human Interleukin 2 Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Recombinant Human Interleukin 2 Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Recombinant Human Interleukin 2 Injection Market Competitive Situation by Manufacturers in 2021 Table 5. Global Recombinant Human Interleukin 2 Injection Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Manufacturers (2017-2022) Table 7. Global Recombinant Human Interleukin 2 Injection Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Recombinant Human Interleukin 2 Injection Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Recombinant Human Interleukin 2 Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Recombinant Human Interleukin 2 Injection Manufacturing Sites and Area Served Table 11. Manufacturers Recombinant Human Interleukin 2 Injection Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Recombinant Human Interleukin 2 Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Interleukin 2 Injection as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Recombinant Human Interleukin 2 Injection Sales by Region (2017-2022) & (K Units) Table 16. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Region (2017-2022) Table 17. Global Recombinant Human Interleukin 2 Injection Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Region (2017-2022) Table 19. North America Recombinant Human Interleukin 2 Injection Sales by Country (2017-2022) & (K Units) Table 20. North America Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2017-2022) Table 21. North America Recombinant Human Interleukin 2 Injection Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Recombinant Human Interleukin 2 Injection Revenue Market Share by Country (2017-2022) Table 23. Europe Recombinant Human Interleukin 2 Injection Sales by Country (2017-2022) & (K Units) Table 24. Europe Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2017-2022) Table 25. Europe Recombinant Human Interleukin 2 Injection Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Recombinant Human Interleukin 2 Injection Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Recombinant Human Interleukin 2 Injection Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Recombinant Human Interleukin 2 Injection Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Recombinant Human Interleukin 2 Injection Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Recombinant Human Interleukin 2 Injection Revenue Market Share by Region (2017-2022) Table 31. Latin America Recombinant Human Interleukin 2 Injection Sales by Country (2017-2022) & (K Units) Table 32. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2017-2022) Table 33. Latin America Recombinant Human Interleukin 2 Injection Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Recombinant Human Interleukin 2 Injection Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Recombinant Human Interleukin 2 Injection Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Recombinant Human Interleukin 2 Injection Revenue Market Share by Country (2017-2022) Table 39. Global Recombinant Human Interleukin 2 Injection Sales by Type (2017-2022) & (K Units) Table 40. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Type (2017-2022) Table 41. Global Recombinant Human Interleukin 2 Injection Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Recombinant Human Interleukin 2 Injection Revenue Share by Type (2017-2022) Table 43. Global Recombinant Human Interleukin 2 Injection Price by Type (2017-2022) & (US$/Unit) Table 44. Global Recombinant Human Interleukin 2 Injection Sales (K Units) by Application (2017-2022) Table 45. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Application (2017-2022) Table 46. Global Recombinant Human Interleukin 2 Injection Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Recombinant Human Interleukin 2 Injection Revenue Share by Application (2017-2022) Table 48. Global Recombinant Human Interleukin 2 Injection Price by Application (2017-2022) & (US$/Unit) Table 49. Jiangsu Jinsili Pharmaceutical Corporation Information Table 50. Jiangsu Jinsili Pharmaceutical Description and Business Overview Table 51. Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Product Table 53. Jiangsu Jinsili Pharmaceutical Recent Developments/Updates Table 54. 3SBio Corporation Information Table 55. 3SBio Description and Business Overview Table 56. 3SBio Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. 3SBio Recombinant Human Interleukin 2 Injection Product Table 58. 3SBio Recent Developments/Updates Table 59. Beijing SL Pharm Corporation Information Table 60. Beijing SL Pharm Description and Business Overview Table 61. Beijing SL Pharm Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Beijing SL Pharm Recombinant Human Interleukin 2 Injection Product Table 63. Beijing SL Pharm Recent Developments/Updates Table 64. Shanghai Huaxin Biology Gaojishu Corporation Information Table 65. Shanghai Huaxin Biology Gaojishu Description and Business Overview Table 66. Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Product Table 68. Shanghai Huaxin Biology Gaojishu Recent Developments/Updates Table 69. Beijing Four Rings Biopharmaceutical Corporation Information Table 70. Beijing Four Rings Biopharmaceutical Description and Business Overview Table 71. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Product Table 73. Beijing Four Rings Biopharmaceutical Recent Developments/Updates Table 74. Beijing Yuance Pharmaceutical Corporation Information Table 75. Beijing Yuance Pharmaceutical Description and Business Overview Table 76. Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Product Table 78. Beijing Yuance Pharmaceutical Recent Developments/Updates Table 79. Shandong Quangang Pharmaceutical Corporation Information Table 80. Shandong Quangang Pharmaceutical Description and Business Overview Table 81. Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Product Table 83. Shandong Quangang Pharmaceutical Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Recombinant Human Interleukin 2 Injection Distributors List Table 87. Recombinant Human Interleukin 2 Injection Customers List Table 88. Recombinant Human Interleukin 2 Injection Market Trends Table 89. Recombinant Human Interleukin 2 Injection Market Drivers Table 90. Recombinant Human Interleukin 2 Injection Market Challenges Table 91. Recombinant Human Interleukin 2 Injection Market Restraints Table 92. Global Recombinant Human Interleukin 2 Injection Sales Forecast by Type (2023-2028) & (K Units) Table 93. Global Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Type (2023-2028) Table 94. Global Recombinant Human Interleukin 2 Injection Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Recombinant Human Interleukin 2 Injection Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Recombinant Human Interleukin 2 Injection Sales Forecast by Application (2023-2028) & (K Units) Table 97. Global Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Application (2023-2028) Table 98. Global Recombinant Human Interleukin 2 Injection Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Recombinant Human Interleukin 2 Injection Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Recombinant Human Interleukin 2 Injection Sales Forecast by Region (2023-2028) & (K Units) Table 101. Global Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Region (2023-2028) Table 102. Global Recombinant Human Interleukin 2 Injection Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Recombinant Human Interleukin 2 Injection Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Recombinant Human Interleukin 2 Injection Figure 2. Global Recombinant Human Interleukin 2 Injection Market Share by Type in 2021 & 2028 Figure 3. 50000 U Product Picture Figure 4. 100000 U Product Picture Figure 5. 200000 U Product Picture Figure 6. 500000 U Product Picture Figure 7. 1 Million U Product Picture Figure 8. Other Product Picture Figure 9. Global Recombinant Human Interleukin 2 Injection Market Share by Application in 2021 & 2028 Figure 10. Hospital Figure 11. Pharmacy Figure 12. Global Recombinant Human Interleukin 2 Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Recombinant Human Interleukin 2 Injection Market Size (2017-2028) & (US$ Million) Figure 14. Global Recombinant Human Interleukin 2 Injection Sales (2017-2028) & (K Units) Figure 15. Recombinant Human Interleukin 2 Injection Sales Share by Manufacturers in 2021 Figure 16. Global Recombinant Human Interleukin 2 Injection Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Recombinant Human Interleukin 2 Injection Players: Market Share by Revenue in 2021 Figure 18. Recombinant Human Interleukin 2 Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Region (2017-2022) Figure 20. Global Recombinant Human Interleukin 2 Injection Sales Market Share by Region in 2021 Figure 21. Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Region (2017-2022) Figure 22. Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Region in 2021 Figure 23. United States Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. China Taiwan Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Recombinant Human Interleukin 2 Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Recombinant Human Interleukin 2 Injection by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Recombinant Human Interleukin 2 Injection Figure 47. Manufacturing Process Analysis of Recombinant Human Interleukin 2 Injection Figure 48. Recombinant Human Interleukin 2 Injection Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Jiangsu Jinsili Pharmaceutical 3SBio Beijing SL Pharm Shanghai Huaxin Biology Gaojishu Beijing Four Rings Biopharmaceutical Beijing Yuance Pharmaceutical Shandong Quangang Pharmaceutical